{"disease":{"id":"hpv-related-cervical-carcinoma","name":"hpv related cervical carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05996783","title":"Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":48000,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT04679675","title":"Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":32771,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT03105856","title":"FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Instituto Nacional de Salud Publica, Mexico","has_results":false},{"nct_id":"NCT05973487","title":"A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":840,"lead_sponsor_name":"TScan Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03493542","title":"A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":766,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04970394","title":"An Observational Study of GP Verbal Reminders Upon Cervical Screening","phase":"","overall_status":"COMPLETED","enrollment_count":724,"lead_sponsor_name":"Dr. Faizan Awan","has_results":false},{"nct_id":"NCT03888599","title":"Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"University Hospital, Geneva","has_results":false},{"nct_id":"NCT05783167","title":"Self-collected Vaginal and Urine Samples in HIV-positive Women","phase":"","overall_status":"COMPLETED","enrollment_count":502,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT04436133","title":"Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":480,"lead_sponsor_name":"National Vaccine and Serum Institute, China","has_results":false},{"nct_id":"NCT04530201","title":"CASUS: Validation for Detection of Precursor Lesions","phase":"NA","overall_status":"COMPLETED","enrollment_count":332,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT03337269","title":"Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake","phase":"NA","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03749707","title":"HPV in Sentinel Lymph Nodes of Cervical Cancer Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06339684","title":"HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT06598176","title":"Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT04083196","title":"A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"National Vaccine and Serum Institute, China","has_results":false},{"nct_id":"NCT06157151","title":"PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Precigen, Inc","has_results":false},{"nct_id":"NCT06052033","title":"Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"First Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT05996796","title":"Dry Run of the ScreenUrSelf Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT04480866","title":"CASUS: Improved and Quality Assured Collection of First-void Urine","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT05061940","title":"This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.","phase":"","overall_status":"TERMINATED","enrollment_count":22,"lead_sponsor_name":"Repertoire Immune Medicines","has_results":false},{"nct_id":"NCT04857528","title":"Detecting HPV DNA in Anal and Cervical Cancers","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT05686226","title":"E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Christian Hinrichs","has_results":false},{"nct_id":"NCT05639972","title":"E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Christian Hinrichs","has_results":false}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}